These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10537155)

  • 1. The luteinizing hormone-releasing hormone receptor in human prostate cancer cells: messenger ribonucleic acid expression, molecular size, and signal transduction pathway.
    Limonta P; Moretti RM; Marelli MM; Dondi D; Parenti M; Motta M
    Endocrinology; 1999 Nov; 140(11):5250-6. PubMed ID: 10537155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
    Gründker C; Völker P; Emons G
    Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D; Limonta P; Moretti RM; Marelli MM; Garattini E; Motta M
    Cancer Res; 1994 Aug; 54(15):4091-5. PubMed ID: 8033142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
    Wells A; Souto JC; Solava J; Kassis J; Bailey KJ; Turner T
    Clin Cancer Res; 2002 Apr; 8(4):1251-7. PubMed ID: 11948140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP.
    Limonta P; Dondi D; Moretti RM; Fermo D; Garattini E; Motta M
    J Clin Endocrinol Metab; 1993 Mar; 76(3):797-800. PubMed ID: 8445038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats.
    Pinski J; Lamharzi N; Halmos G; Groot K; Jungwirth A; Vadillo-Buenfil M; Kakar SS; Schally AV
    Endocrinology; 1996 Aug; 137(8):3430-6. PubMed ID: 8754771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.
    Moretti RM; Marelli MM; Dondi D; Poletti A; Martini L; Motta M; Limonta P
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3930-7. PubMed ID: 8923840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupling of gonadotropin-releasing hormone receptor to Gi protein in human reproductive tract tumors.
    Imai A; Takagi H; Horibe S; Fuseya T; Tamaya T
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3249-53. PubMed ID: 8784077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of G(q/11)alpha by the gonadotropin-releasing hormone receptor.
    Stanislaus D; Janovick JA; Brothers S; Conn PM
    Mol Endocrinol; 1997 Jun; 11(6):738-46. PubMed ID: 9171237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers.
    Halmos G; Arencibia JM; Schally AV; Davis R; Bostwick DG
    J Urol; 2000 Feb; 163(2):623-9. PubMed ID: 10647698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the messenger RNAs for luteinizing hormone-releasing hormone (LHRH) and its receptor in human ovarian epithelial carcinoma.
    Irmer G; Bürger C; Müller R; Ortmann O; Peter U; Kakar SS; Neill JD; Schulz KD; Emons G
    Cancer Res; 1995 Feb; 55(4):817-22. PubMed ID: 7850795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The third intracellular loop of the rat gonadotropin-releasing hormone receptor couples the receptor to Gs- and G(q/11)-mediated signal transduction pathways: evidence from loop fragment transfection in GGH3 cells.
    Ulloa-Aguirre A; Stanislaus D; Arora V; Väänänen J; Brothers S; Janovick JA; Conn PM
    Endocrinology; 1998 May; 139(5):2472-8. PubMed ID: 9564860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
    Limonta P; Dondi D; Moretti RM; Maggi R; Motta M
    J Clin Endocrinol Metab; 1992 Jul; 75(1):207-12. PubMed ID: 1320049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
    Stangelberger A; Schally AV; Nagy A; Szepeshazi K; Kanashiro CA; Halmos G
    Prostate; 2006 Feb; 66(2):200-10. PubMed ID: 16173040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells.
    Marelli MM; Moretti RM; Dondi D; Motta M; Limonta P
    Endocrinology; 1999 Jan; 140(1):329-34. PubMed ID: 9886842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An agonist-induced switch in G protein coupling of the gonadotropin-releasing hormone receptor regulates pulsatile neuropeptide secretion.
    Krsmanovic LZ; Mores N; Navarro CE; Arora KK; Catt KJ
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2969-74. PubMed ID: 12591945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
    Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
    Clin Cancer Res; 2001 Aug; 7(8):2340-3. PubMed ID: 11489810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of LHRH agonists on the growth of human prostatic tumor cells: "in vitro" and "in vivo" studies.
    Montagnani Marelli M; Moretti RM; Dondi D; Limonta P; Motta M
    Arch Ital Urol Androl; 1997 Sep; 69(4):257-63. PubMed ID: 9396187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pertussis toxin-sensitive G-protein mediates the alpha 2-adrenergic receptor inhibition of melatonin release in photoreceptive chick pineal cell cultures.
    Pratt BL; Takahashi JS
    Endocrinology; 1988 Jul; 123(1):277-83. PubMed ID: 2838256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.